hardycascapedia234| *ST Target Drug (600671.SH): Huangshan Tianmu plans to implement 100 million yuan capacity improvement and technological transformation projects
Gelonghui May 23 δΈ¨*ST Eye Medicine (600671hardycascapedia234.SH) Announcementhardycascapedia234, the company's wholly-owned subsidiary, Huangshan City Tianmu Pharmaceutical Co., Ltd., plans to implement production capacity improvement and technological transformation projects, with an estimated total investment of 100 million yuan. Huangshan Tianmu will build a new production workshop in the existing factory area, optimize and transform the original production line, increase production capacity, and build an intelligent, digital and information-based factory.
